GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (OTCPK:OXBDF) » Definitions » 12-1 Month Momentum %

Oxford BioMedica (Oxford BioMedica) 12-1 Month Momentum % : -50.55% (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Oxford BioMedica 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-26), Oxford BioMedica's 12-1 Month Momentum % is -50.55%.

The industry rank for Oxford BioMedica's 12-1 Month Momentum % or its related term are showing as below:

OXBDF's 12-1 Month Momentum % is ranked worse than
72.65% of 1477 companies
in the Biotechnology industry
Industry Median: -25.71 vs OXBDF: -50.55

Competitive Comparison of Oxford BioMedica's 12-1 Month Momentum %

For the Biotechnology subindustry, Oxford BioMedica's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioMedica's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's 12-1 Month Momentum % falls into.



Oxford BioMedica  (OTCPK:OXBDF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioMedica  (OTCPK:OXBDF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Oxford BioMedica 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioMedica (Oxford BioMedica) Business Description

Traded in Other Exchanges
Address
Windrush Court, Transport Way, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.